白藜芦醇对代谢综合征无有益作用:一项随机安慰剂对照临床试验
在丹麦奥胡斯大学医院开展随机、安慰剂对照、双盲、平行组临床试验,74例中年社区男性代谢综合征患者随机接受每日1000 mg白藜芦醇、150 mg白藜芦醇或安慰剂共16周,66例完成所有访视。白藜芦醇未改善炎症状态、血糖稳态、血压或肝脏脂质含量,高剂量白藜芦醇反而显著升高总胆固醇、低密度脂蛋白胆固醇和果糖胺水平。
要点
- 白藜芦醇未降低血浆高敏C反应蛋白、白细胞介素6或可溶性尿激酶纤溶酶原激活物受体水平。
- 白藜芦醇对血压、体成分、肝脏或横纹肌脂质沉积及糖脂代谢均无有益作用。
- 高剂量白藜芦醇较安慰剂显著升高总胆固醇(P < 0.002)、低密度脂蛋白胆固醇(P < 0.006)和果糖胺(P < 0.013)。
核心结论
- 白藜芦醇治疗未改善中年代谢综合征男性的炎症状态、血糖稳态、血压或肝脏脂质含量。
- 相反,高剂量白藜芦醇较安慰剂显著升高总胆固醇、低密度脂蛋白胆固醇和果糖胺水平。
研究设计与样本
- 随机、安慰剂对照、双盲、平行组临床试验,在奥胡斯大学医院开展。
- 共纳入74例中年社区男性代谢综合征患者,66例完成所有访视(均值±均值标准误):年龄49.5 ± 0.796岁;体重指数33.8 ± 0.44 kg/m2;腰围115 ± 1.14 cm。
- 干预为每日口服补充1000 mg白藜芦醇(高剂量组)、150 mg白藜芦醇或安慰剂,持续16周。
主要发现
- 白藜芦醇未降低血浆高敏C反应蛋白、白细胞介素6或可溶性尿激酶纤溶酶原激活物受体水平,脂肪和肌肉组织中炎症基因表达亦无变化。
- 白藜芦醇对血压、体成分、肝脏或横纹肌脂质沉积无影响。
- 白藜芦醇对糖代谢或脂代谢无有益作用。
- 高剂量白藜芦醇组较安慰剂组显著升高总胆固醇(P < 0.002)、低密度脂蛋白胆固醇(P < 0.006)和果糖胺(P < 0.013)水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Low-grade inflammation is associated with obesity and the metabolic syndrome (MetS). Preclinical evidence suggests that resveratrol (RSV) has beneficial metabolic and anti-inflammatory effects that could have therapeutic implications. OBJECTIVE: To investigate effects of long-term RSV treatment on inflammation and MetS. SETTING AND DESIGN: A randomized, placebo-controlled, double-blind, parallel group clinical trial conducted at Aarhus University Hospital. PARTICIPANTS: Middle-aged community-dwelling men (N = 74) with MetS, 66 of whom completed all visits (mean ± standard error of the mean): age, 49.5 ± 0.796 years; body mass index, 33.8 ± 0.44 kg/m2; waist circumference, 115 ± 1.14 cm. INTERVENTION: Daily oral supplementation with 1000 mg RSV (RSVhigh), 150 mg RSV, or placebo for 16 weeks. MAIN OUTCOME MEASURES: Plasma levels of high-sensitivity C-reactive protein (hs-CRP), circulating lipids, and inflammatory markers in circulation and adipose/muscle tissue biopsy specimens; glucose metabolism; and body composition including visceral fat and ectopic fat deposition. RESULTS: RSV treatment did not lower circulating levels of hs-CRP, interleukin 6, or soluble urokinase plasminogen activator receptor in plasma, and inflammatory gene expression in adipose and muscle tissues also remained unchanged. RSV treatment had no effect on blood pressure, body composition, and lipid deposition in the liver or striated muscle. RSV treatment had no beneficial effect on glucose or lipid metabolism. RSVhigh treatment significantly increased total cholesterol (P < 0.002), low-density lipoprotein (LDL) cholesterol (P < 0.006), and fructosamine (P < 0.013) levels compared with placebo. CONCLUSION: RSV treatment did not improve inflammatory status, glucose homeostasis, blood pressure, or hepatic lipid content in middle-aged men with MetS. On the contrary, RSVhigh significantly increased total cholesterol, LDL cholesterol, and fructosamine levels compared with placebo.
引用
- Kjær TN, Ornstrup MJ, Poulsen MM, et al. No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial. J Clin Endocrinol Metab. 2017. PMID: 28182820. doi:10.1210/jc.2016-2160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。